AMR Mobile, previously called Coastal Clinical Research (CCR),[1] is an American clinical research center in Mobile, Alabama. It is a subsidiary of the Alliance for Multispecialty Research (AMR).
History
According to owner Kathy Welch, the company "is the oldest clinical research site in Alabama and has worked on vaccines like Ebola and Swine Flu."[2]
COVID-19
CCR was a trial site for the Pfizer-BioNTech COVID-19 vaccine clinical trial, led by Harry Studdard as site investigator.[3][4] Residents from Mississippi to Florida were eligible to apply, and were provided "free medical services and a stipend."[2:1]
External links
Home. Coastal Clinical Research | Mobile, Alabama. Retrieved May 7, 2023, from https://web.archive.org/web/20230507084829/https://www.coastalclinicalresearch.com/ ↩︎
Winter, D. (2020, June 5). Only on News 5: Alabama’s first COVID-19 vaccine trial coming to Mobile. WKRG News 5. http://archive.today/2023.08.21-032418/https://www.wkrg.com/news/only-on-news-5-alabamas-first-covid-19-vaccine-trial-coming-to-mobile/ ↩︎ ↩︎
BioNTech SE. (2023, February 28). Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov. https://web.archive.org/web/20230804070226/https://classic.clinicaltrials.gov/ct2/show/NCT04368728 ↩︎
Supplementary Appendix (p. 2). (2021). medRxiv. https://web.archive.org/web/20230826041437/https://www.medrxiv.org/content/medrxiv/early/2021/07/28/2021.07.28.21261159/DC1/embed/media-1.pdf ↩︎
